Tesla shares (TSLA)

Key Updates

Tesla shares advanced 2.29% to $360.63 since the April 13 report, representing a modest technical recovery within a persistent downtrend that has eroded 19.81% of shareholder value year-to-date. The stock continues trading well below its 6-month trajectory (-15.98%), though short-term momentum shows stabilization with gains of 2.33% over one day and 4.03% over five days. The monthly decline of 7.81% underscores ongoing structural headwinds. Two significant developments emerged: Tesla has officially discontinued custom orders for Model S and Model X vehicles, pivoting entirely toward autonomous vehicle production with Cybercab mass production commencing this month, while Q1 2026 delivery results of 358,023 units fell short of analyst expectations, intensifying concerns that Tesla is "actively sacrificing" its core EV business to fund capital-intensive AI and robotics ventures.

Current Trend

Tesla remains entrenched in a bearish trend with YTD losses of 19.81%, reflecting sustained selling pressure across all medium-term timeframes. The 6-month decline of 15.98% confirms deteriorating investor sentiment following disappointing operational metrics and aggressive capital allocation toward unproven technologies. Recent price action shows modest stabilization at the $360 level, with 5-day gains of 4.03% suggesting potential short-term support formation. However, the 1-month decline of 7.81% indicates that each rally faces immediate resistance, consistent with a distribution pattern where investors use strength to exit positions. The stock's inability to recover meaningfully from YTD lows despite broader market stability suggests company-specific concerns outweigh sector dynamics.

Investment Thesis

The investment thesis for Tesla has fundamentally shifted from a traditional automotive growth story to a high-risk, capital-intensive technology transformation bet. Management is deliberately deprioritizing the profitable EV business—which generated $69.5 billion in revenue in 2025, more than double all other segments combined—to pursue autonomous vehicles, humanoid robots, and semiconductor manufacturing. This strategic pivot requires capital expenditures exceeding $20 billion in 2026 excluding the Terafab semiconductor project, which UBS estimates could ultimately require $300 billion at full capacity. Free cash flow is projected to turn negative for the first time since 2018, with analysts forecasting -$4.1 billion in 2026. The thesis now hinges on Tesla successfully executing multiple moonshot projects simultaneously while maintaining sufficient liquidity and investor confidence during an extended cash-burn phase. The discontinuation of Model S and Model X, combined with underperforming Q1 deliveries and weak energy storage deployments (8.8 GWh versus 14.4 GWh expected), signals management's willingness to sacrifice near-term profitability for long-term technological leadership.

Thesis Status

The investment thesis has deteriorated significantly since previous reports, with new evidence confirming the strategic abandonment of Tesla's core automotive business. The discontinuation of Model S and Model X custom orders represents a definitive inflection point, eliminating products that peaked at 101,312 combined units in 2017. Q1 2026 deliveries of 358,023 units missed both FactSet consensus (381,000) and Tesla's compiled analyst consensus (365,645), while energy storage deployments underperformed by 39%—the weakest quarter since Q3 2024. Analyst commentary that Tesla is "actively sacrificing" its EV business aligns with observable operational trends. The positive development in European sales growth of 29% year-over-year in February provides limited offset given the magnitude of global delivery misses. The thesis now depends entirely on successful execution of Cybercab production, Optimus robot commercialization, and the Terafab chip manufacturing venture—none of which have demonstrated commercial viability or regulatory approval.

Key Drivers

Strategic Product Transition: Tesla has ended custom orders for Model S and Model X, with Cybercab mass production beginning this month in Austin and Optimus robot production expected at Fremont. This represents a complete strategic pivot from traditional automotive manufacturing to autonomous and robotics platforms, creating significant execution risk alongside potential long-term optionality.

Operational Underperformance: Q1 2026 deliveries of 358,023 units fell short of analyst expectations, representing only 6% year-over-year growth. Energy storage deployments of 8.8 GWh missed expectations by 39%, marking the weakest quarter since Q3 2024 and raising concerns about deterioration across multiple business segments beyond automotive.

Capital Intensity and Cash Flow: Tesla faces capital expenditures exceeding $20 billion in 2026, with the Terafab semiconductor project potentially requiring $30 billion initially and $300 billion at full capacity. Free cash flow is projected to turn negative at -$4.1 billion in 2026, the first negative FCF year since 2018, despite holding $44 billion in cash at year-end 2025.

European Market Recovery: Tesla achieved first sales growth in Europe in over a year, with EU registrations reaching 13,740 units in February 2026, up 29% year-over-year, driven by cheaper Model Y and Model 3 variants and sales incentives. Regulatory approval for Full Self-Driving software in Europe is expected during summer 2025, potentially opening new revenue streams.

Regulatory and Technical Hurdles: The Cybercab faces significant barriers to commercial operation, requiring federal safety exemptions and demonstration of reliable autonomous driving capabilities. The automotive business generated $69.5 billion in revenue last year—more than double the rest of the company—making the transition away from traditional EVs particularly risky during a capital-intensive expansion phase.

Technical Analysis

Tesla is trading at $360.63, showing short-term stabilization with gains of 2.33% over one day and 4.03% over five days, suggesting potential support formation near the $350 level. However, the stock remains in a confirmed downtrend with YTD losses of 19.81% and 6-month losses of 15.98%. The 1-month decline of 7.81% indicates that rallies face immediate selling pressure, consistent with a distribution pattern where institutional investors use strength to reduce exposure. The recent bounce from the April 13 report (+2.29%) lacks conviction, occurring on no significant fundamental catalyst and representing merely a technical relief rally within the broader bearish structure. Key resistance likely exists at the $375-$380 range, while support appears tentative at $350. The stock's failure to reclaim losses despite broader market stability suggests company-specific headwinds dominate price action. Volume patterns and momentum indicators would be necessary to assess whether the current stabilization represents genuine accumulation or a temporary pause before further declines.

Bull Case

• European Market Momentum: Tesla achieved 29% year-over-year sales growth in EU registrations during February 2026, marking the first growth in over a year, with cheaper Model Y and Model 3 variants driving adoption and Full Self-Driving regulatory approval expected in summer 2025. Source
• Cybercab Production Commencing: Mass production of the autonomous Cybercab begins this month in Austin, Texas, representing a potential first-mover advantage in the robotaxi market if regulatory approval is obtained and technical reliability demonstrated. Source
• Vertical Integration via Terafab: The chip manufacturing facility launching within 7 days addresses Tesla's assertion that current partners (TSMC, Samsung, Micron) cannot meet future AI chip demand, potentially creating competitive advantages in AI computing and reducing supply chain dependencies. Source
• Strong Cash Position: Tesla held $44 billion in cash at year-end 2025, providing substantial liquidity to fund capital-intensive projects during the transition phase despite projected negative free cash flow of $4.1 billion in 2026. Source
• Optimus Robot Production Launch: Humanoid robot production expected to begin at the Fremont factory represents entry into a potentially massive robotics market, leveraging Tesla's AI and manufacturing capabilities into new revenue streams. Source

Bear Case

• Core Business Deterioration: Q1 2026 deliveries of 358,023 units missed analyst expectations by 7,000-23,000 units, while energy storage deployments underperformed by 39%, indicating weakness across multiple segments as management "actively sacrifices" the profitable EV business that generated $69.5 billion in 2025 revenue. Source
• Negative Free Cash Flow Trajectory: Analysts project Tesla's free cash flow will turn negative at -$4.1 billion in 2026 for the first time since 2018, driven by capital expenditures exceeding $20 billion excluding Terafab costs, which could ultimately require $300 billion at full production capacity. Source
• Product Line Contraction: The discontinuation of Model S and Model X custom orders eliminates products that peaked at 101,312 combined units in 2017, with no traditional lower-cost EV replacement planned, reducing revenue diversity and increasing dependence on unproven autonomous technologies. Source
• Regulatory and Technical Uncertainty: Cybercab faces significant hurdles including federal safety exemptions and demonstration of reliable autonomous driving before commercial operation, while the Terafab semiconductor venture enters a capital-intensive industry with established competitors and uncertain returns. Source
• Execution Risk Across Multiple Moonshots: Tesla is simultaneously pursuing Cybercab production, Optimus robot commercialization, Terafab chip manufacturing, and potential SpaceX merger speculation, creating unprecedented execution complexity while the automotive business that funds these ventures shows declining growth momentum. Source